Schroder et al. have also shown that high UCHL1 expression is negatively correlated with ER and progesterone receptor (PR) expression, and positively correlated with advanced tumour stage and shorter overall survival times for breast cancer patients (Fig. S1), further supporting a prominent role for UCHL1 in breast cancer progression [49]. The gene discussed is PGR; the disease is breast carcinoma.